Aravive Inc - Common / Ordinary Stock (ARAV)

CUSIP: 03890D108

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / Common / Ordinary Stock
Total 13F shares
1,930,569
Share change
+1,372,060
Total reported value
$6,792,000
Put/Call ratio
44%
Price per share
$3.52
Number of holders
32
Value change
+$4,856,029
Number of buys
28
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 03890D108?
CUSIP 03890D108 identifies ARAV - Aravive Inc - Common / Ordinary Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Aravive Inc - Common / Ordinary Stock (ARAV) as of Q4 2018

As of 31 Dec 2018, Aravive Inc - Common / Ordinary Stock (ARAV) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,930,569 shares. The largest 10 holders included Samsara BioCapital, LLC, BAKER BROS. ADVISORS LP, BlackRock Inc., Board of Trustees of The Leland Stanford Junior University, DIMENSIONAL FUND ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, Vanguard Group Inc, NF Trinity Capital (Hong Kong) Ltd, TWO SIGMA INVESTMENTS, LP, and UBS Group AG. This page lists 32 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.